NYSE:SEM

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Select Medical Holdings

Market Cap

US$5.3b

Last Updated

2021/08/01 22:19 UTC

Data Sources

Company Financials +

Executive Summary

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. More Details


Snowflake Analysis

Proven track record with adequate balance sheet.


Similar Companies

Share Price & News

How has Select Medical Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: SEM is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 4% a week.

Volatility Over Time: SEM's weekly volatility (4%) has been stable over the past year.


Market Performance


7 Day Return

0.5%

SEM

-1.3%

US Healthcare

-0.4%

US Market


1 Year Return

107.2%

SEM

33.6%

US Healthcare

35.9%

US Market

Return vs Industry: SEM exceeded the US Healthcare industry which returned 33.6% over the past year.

Return vs Market: SEM exceeded the US Market which returned 35.9% over the past year.


Shareholder returns

SEMIndustryMarket
7 Day0.5%-1.3%-0.4%
30 Day-7.5%-1.1%-0.3%
90 Day3.5%0.5%3.1%
1 Year107.9%107.2%35.3%33.6%38.0%35.9%
3 Year96.4%95.8%50.4%44.3%62.9%52.7%
5 Year223.1%222.0%100.4%85.4%121.3%96.9%

Long-Term Price Volatility Vs. Market

How volatile is Select Medical Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Select Medical Holdings undervalued compared to its fair value and its price relative to the market?

16.67x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: SEM ($39.45) is trading above our estimate of fair value ($25.88)

Significantly Below Fair Value: SEM is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: SEM is good value based on its PE Ratio (16.7x) compared to the US Healthcare industry average (22.4x).

PE vs Market: SEM is good value based on its PE Ratio (16.7x) compared to the US market (18.1x).


Price to Earnings Growth Ratio

PEG Ratio: SEM is poor value based on its PEG Ratio (1.2x)


Price to Book Ratio

PB vs Industry: SEM is overvalued based on its PB Ratio (4.6x) compared to the US Healthcare industry average (3.7x).


Future Growth

How is Select Medical Holdings forecast to perform in the next 1 to 3 years based on estimates from 5 analysts?

14.5%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: SEM's forecast earnings growth (14.5% per year) is above the savings rate (2%).

Earnings vs Market: SEM's earnings (14.5% per year) are forecast to grow slower than the US market (15% per year).

High Growth Earnings: SEM's earnings are forecast to grow, but not significantly.

Revenue vs Market: SEM's revenue (4.1% per year) is forecast to grow slower than the US market (9.2% per year).

High Growth Revenue: SEM's revenue (4.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: SEM's Return on Equity is forecast to be high in 3 years time (23.8%)


Past Performance

How has Select Medical Holdings performed over the past 5 years?

14.4%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: SEM has a large one-off gain of $129.2M impacting its March 31 2021 financial results.

Growing Profit Margin: SEM's current net profit margins (5.4%) are higher than last year (2.8%).


Past Earnings Growth Analysis

Earnings Trend: SEM's earnings have grown by 14.4% per year over the past 5 years.

Accelerating Growth: SEM's earnings growth over the past year (95.8%) exceeds its 5-year average (14.4% per year).

Earnings vs Industry: SEM earnings growth over the past year (95.8%) exceeded the Healthcare industry 43.9%.


Return on Equity

High ROE: Whilst SEM's Return on Equity (22.9%) is high, this metric is skewed due to their high level of debt.


Financial Health

How is Select Medical Holdings's financial position?


Financial Position Analysis

Short Term Liabilities: SEM's short term assets ($1.8B) exceed its short term liabilities ($1.5B).

Long Term Liabilities: SEM's short term assets ($1.8B) do not cover its long term liabilities ($4.6B).


Debt to Equity History and Analysis

Debt Level: SEM's debt to equity ratio (188.7%) is considered high.

Reducing Debt: SEM's debt to equity ratio has reduced from 229.9% to 188.7% over the past 5 years.

Debt Coverage: SEM's debt is well covered by operating cash flow (36.1%).

Interest Coverage: SEM's interest payments on its debt are well covered by EBIT (3.8x coverage).


Balance Sheet


Dividend

What is Select Medical Holdings's current dividend yield, its reliability and sustainability?

1.27%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: SEM's dividend (1.27%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.31%).

High Dividend: SEM's dividend (1.27%) is low compared to the top 25% of dividend payers in the US market (3.55%).


Stability and Growth of Payments

Stable Dividend: SEM has been paying a dividend for less than 10 years and during this time payments have been volatile.

Growing Dividend: SEM's dividend payments have increased, but the company has only paid a dividend for 8 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (5.3%), SEM's dividend payments are thoroughly covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

21.4yrs

Average management tenure


CEO

David Chernow (64 yo)

7.5yrs

Tenure

US$7,534,275

Compensation

Mr. David S. Chernow has been the Chief Executive Officer at Select Medical Holdings Corporation and Select Medical Corporation since January 1, 2014. Mr. Chernow serves as Chairman of the Board at OneOnco...


CEO Compensation Analysis

Compensation vs Market: David's total compensation ($USD7.53M) is about average for companies of similar size in the US market ($USD6.51M).

Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: SEM's management team is seasoned and experienced (21.4 years average tenure).


Board Members

Experienced Board: SEM's board of directors are considered experienced (7.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: SEM insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Select Medical Holdings Corporation's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Select Medical Holdings Corporation
  • Ticker: SEM
  • Exchange: NYSE
  • Founded: 1996
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: US$5.319b
  • Shares outstanding: 134.84m
  • Website: https://www.selectmedical.com

Number of Employees


Location

  • Select Medical Holdings Corporation
  • 4714 Gettysburg Road
  • PO Box 2034
  • Mechanicsburg
  • Pennsylvania
  • 17055
  • United States

Listings


Biography

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occup...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/08/01 22:19
End of Day Share Price2021/07/30 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.